Blog

23 Articles

long-term pancreatic cancer survivor Elizabeth O'Connor and her family
Survivor Stories
April 11, 2022 • 6 Min

Cherishing the Simple Things

Elizabeth O’Connor has a PALB2 genetic mutation so her stage IV pancreatic cancer has responded to immunotherapy.

Kim Reiss Binder
Research
January 12, 2022 • 5 Min

New Study Aims to Reduce Recurrence Risk for Select Patients

Dr. Kim A. Reiss is leading a study of the PARP inhibitor olaparib to delay or prevent a recurrence of surgically removed pancreatic cancer.

pancreatic cancer long-term survivor Helene Avraham-Katz and her family
Survivor Stories
September 23, 2021 • 5 Min

The Butterfly Effect and Living Every Day to My Fullest

Because Helene Avraham-Katz has the BRCA2 mutation, certain chemotherapies work better and she is eligible for specific clinical trials.

orange and blue kaleidoscopic pattern
Research
August 11, 2021 • 2 Min

Testing a PARP Inhibitor for Metastatic Pancreatic Cancer Patients with DNA Repair Mutations

Researchers are testing a PARP inhibitor that is effective for cancers in pancreatic cancer patients with DNA repair mutations.

pancreatic cancer patient Chris Treubert
Survivor Stories
May 28, 2021 • 3 Min

BRCA Mutation Determines My Pancreatic Cancer Treatment

Chris Treubert started with one type of chemotherapy but when the results of genetic testing showed a BRCA mutation he changed treatment.

pancreatic cancer patient Irma Infante
Survivor Stories
November 30, 2020 • 4 Min

A Second Opinion Makes the Difference

Irma Infante refused to give up after a stage IV pancreatic cancer diagnosis. She went for a second opinion and better treatment options.

pancreatic cancer patient Harvey Parker and his wife and daughters
Survivor Stories
April 24, 2020 • 5 Min

Genetic Testing Leads Me to a PARP Inhibitor Trial

Harvey Parker had genetic testing as part of his initial pancreatic cancer treatment. The BRCA2 mutation led him to a PARP inhibitor clinical trial.

Pancreatic cancer patient Davi D'Agostino with student paintings on a river cruise ship
Survivor Stories
February 10, 2020 • 5 Min

My Pancreatic Cancer Clinical Trial Journey

After starting pancreatic cancer treatment, Davi D’Agostino discovered she has the BRCA2 mutation, which made her eligible for a clinical trial.

Gloria Peterson, Ph.D.
Research
February 4, 2019 • 5 Min

Genetic Testing for All Pancreatic Cancer Patients

A study by Dr. Gloria Petersen’s research team has led to an official recommendation that all pancreatic cancer patients get genetic testing.

Old medicine bottles
Research
January 22, 2019 • 4 Min

A PARP Inhibitor Approval for Pancreatic Cancer

PARP inhibitors, a type of targeted therapy, are being studied as treatment for pancreatic cancer in a number of clinical trials.

A human epithelial cell (DNA in blue) with increased numbers of centrosomes (green) amid a sea of normal cells.
Research
January 14, 2019 • 2 Min

Combining Immunotherapy and Targeted Therapy for Pancreatic Cancer

Researchers are combining immunotherapy and targeted therapy in a clinical trial for pancreatic cancer patients on platinum-based chemotherapy.

Kim Reiss Binder
Research
November 1, 2018 • 5 Min

PARP Inhibitors for Pancreatic Cancer Maintenance Treatment

Dr. Kim Reiss Binder is leading a clinical trial of maintenance treatment with the PARP inhibitor rucaparib, for patients who carry the BRCA mutation.

Doron Broman, center left, surrounded by others includ Dr. Kimmie Ng on the far right.
Survivor Stories
October 23, 2018 • 2 Min

Molecular Sequencing Leads to Customized Treatment

When Florida resident Doron Broman was diagnosed with stage IV pancreatic cancer, his decision to get treated in Boston gave him access a PARP inhibitor for maintenance.

Dr. Aimee Lucas
Research
October 19, 2018 • 4 Min

Which Is the Best Screening Method for Pancreatic Cancer?

Dr. Aimee Lucas outlines the pros and cons of various screening methods that can be used for pancreatic cancer, and who should be using them.

Dr. Paul Silverstein, pancreatic cancer patients
Survivor Stories
June 13, 2018 • 7 Min

Aiming to be More than a Statistic

Dr. Paul Silverstein knew that he needed genomic testing, immunotherapy, and a clinical trial in his battle with pancreatic cancer.

  • 1
  • 2